Pharmaceutical industry more than doubles its money as a consequence of the H1N1 scam
Paul Joseph Watson
Wednesday, October 14, 2009
Pharmaceutical corporations are reaping obscene profits as a result of the media fearmongering behind the swine flu outbreak, despite the fact that the H1N1 virus has killed far less people that the seasonal flu.
According to a new ABC News report out today entitled, Drugmakers, Doctors Rake in Billions Battling H1N1 Flu, “Drug companies have sold $1.5 billion worth of swine flu shots, in addition to the $1 billion for seasonal flu they booked earlier this year. These inoculations are part of a much wider and rapidly growing $20 billion global vaccine market.”
U.S. taxpayers have footed the bill for 250 million swine flu vaccines that the government has ordered so far, with Sanofi-Pasteur, Glaxo Smith Kline and Novartis taking most of the profits.
Doctors are also being paid for each vaccination they administer, introducing a financial motive for them to push the inoculation despite fears about the dangerous additives contained in the shot.
Companies outside of the medical industry, such as supermarkets who are offering the flu shots as well as delivery companies like UPS are also enjoying the windfall from a mass propaganda campaign that is brow-beating Americans into taking the shot despite the fact that the swine flu virus has proven far less deadly than the regular flu virus.
(ARTICLE CONTINUES BELOW)
The fact that big pharma has more than doubled its usual income from flu vaccines illustrates the motivation behind why the pharmaceutical lobby has been busy fearmongering about swine flu since it first emerged in Mexico earlier this year.
The establishment media has embarked upon an agenda to smear rising public opposition and suspicion towards the vaccination campaign as the product of the “anti-vaccine lobby,” attempting to attach a sense of malevolence to what amounts to a mere handful of health professionals warning about the dangers of the shot in comparison with the behemoth pharmaceutical lobby that is pushing it.
As we reported earlier, the pharmaceutical lobby is an industry that has no less than 1,274 registered lobbyists in Washington D.C. alone and spent around $900 million on lobbying between 1998 and 2005, more than any other industry. Big pharma lobbied on at least 1,600 pieces of legislation between 1998 and 2004.
As a money making scheme, the swine flu scam has proven immensely profitable for big pharma during a climate where they would normally be struggling to stay afloat, in the middle of an economic recession.
This article was posted: Wednesday, October 14, 2009 at 10:48 am